Registrational phase II/III trial of long-acting C-peptide (CBX129801) in patients with diabetic peripheral neuropathy.
Phase of Trial: Phase II/III
Latest Information Update: 01 Jun 2012
At a glance
- Drugs C-peptide (Primary)
- Indications Diabetic neuropathies
- Focus Registrational; Therapeutic Use
- 01 Jun 2012 Status changed from not yet recruiting to recruiting (the phase II portion of the trial is underway).
- 25 Jun 2011 New trial record